Drugs / Fluoromethyl hexafluoroisopropyl ether
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT03005860 Comparator | Jan 2017 → Oct 2020 | breast cancer | Tata Memorial Centre | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluoromethyl hexafluoroisopropyl ether | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03005860 ↗ |
| Route | Inhaled | “maintenance with O2 with air 50:50%, sevoflurane 2-2.5 %” NCT03005860 ↗ |